WANBURY LIMITED
WANBURY · General/Diversified · NSE
₹265
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for WANBURY yet. Reason: Data Limited.
Updated just now
YieldIQ Score
—
Piotroski F-Score
5/9
Economic Moat
Moderate
Confidence
32%
ROE
51.5%
Debt/Equity
2.98
WACC
11.1%
Market Cap
₹925.54 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
33.8%
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
1.8×
EBIT covers interest
Current Ratio
1.11×
Short-term liquidity
Asset Turnover
1.37×
Revenue per ₹ of assets
Revenue CAGR (3Y)
9.3%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
Ratio Trends
WANBURY · last 4 annual periods
ROE
51.5%
ROCE
33.8%
Operating Margin
—
Debt / Equity
2.98×
PE
—
EV / EBITDA
—
Historical Financials
WANBURY · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 NSE_XBRL | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹393 Cr | ₹507 Cr | ₹498 Cr | ₹574 Cr | ₹594 Cr | +10.9% |
| EBITDA | — | ₹113 Cr | ₹23.5 Cr | ₹98.5 Cr | ₹79.8 Cr | -8.4% |
| EBIT | ₹10.7 Cr | ₹102 Cr | ₹11.1 Cr | ₹85.5 Cr | — | +68.3% |
| PAT | ₹-12.6 Cr | ₹81.5 Cr | ₹-10.4 Cr | ₹56.0 Cr | ₹30.5 Cr | — |
| EPS (diluted) | ₹-5.04 | ₹1.58 | ₹-3.00 | ₹9.18 | — | — |
| CFO | ₹16.7 Cr | ₹40.5 Cr | ₹19.8 Cr | ₹4.7 Cr | ₹26.1 Cr | +11.8% |
| CapEx | — | ₹-9.7 Cr | ₹-12.6 Cr | ₹-17.4 Cr | ₹-49.0 Cr | — |
| FCF | — | ₹30.9 Cr | ₹7.2 Cr | ₹-12.7 Cr | ₹-22.9 Cr | — |
| Total Assets | — | ₹353 Cr | ₹304 Cr | ₹343 Cr | ₹414 Cr | +4.1% |
| Total Debt | — | ₹108 Cr | ₹109 Cr | ₹116 Cr | ₹177 Cr | +13.2% |
| Shareholders' Equity | — | ₹-23.4 Cr | ₹-32.8 Cr | ₹27.9 Cr | ₹59.3 Cr | — |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
WANBURY vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
SIGACHI SIGACHI | — | — | Pending | 11.3% | — |
 THEMISMED THEMISMED | — | — | Pending | 7.4% | — |
ANUHPHR ANUHPHR | — | — | Pending | 11.7% | — |
AHCL AHCL | — | — | Pending | 25.5% | — |
AMANTA AMANTA | — | — | Pending | 6.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for WANBURY in the last 10 years.
Risk Analysis
Volatility & drawdown
Risk profile of WANBURY →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for WANBURY →
Compare
Head-to-head with peers
Compare WANBURY side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse WANBURYNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.